NCT00700687View on ClinicalTrials.gov

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

PHASE1CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Healthy
Interventions
DRUG

PA32540

aspirin/omeprazole

DRUG

PA32540 and celecoxib

aspirin/omeprazole and celecoxib

DRUG

aspirin and [NSAID]

aspirin and \[NSAID\]

Trial Locations (1)

Unknown

Anaheim

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00700687 - Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib | Biotech Hunter | Biotech Hunter